The potential of non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention.
Monica M
MM
Bertagnolli
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017209:Apoptosis; D001095:Arachidonic Acids / Q000378:metabolism; D001241:Aspirin / Q000494:pharmacology; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D015777:Eicosanoids / Q000096:biosynthesis / Q000502:physiology; D006801:Humans; D008563:Membrane Lipids / Q000378:metabolism / Q000502:physiology; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism / Q000502:physiology; D011453:Prostaglandins / Q000378:metabolism / Q000502:physiology; D011817:Rabbits; D011982:Receptors, Prostaglandin / Q000378:metabolism
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D001095:Arachidonic Acids; D015777:Eicosanoids; D008563:Membrane Lipids; D011453:Prostaglandins; D011982:Receptors, Prostaglandin; D011451:Prostaglandin-Endoperoxide Synthases; D001241:Aspirin